AB-82-EP26_0.01uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.01uM, 4-[1-[2-(Cyclopentylamino)pyrimidin-4-yl]-2-[3-(trifluoromethyl)phenyl]imidazol-4-yl]-1-methylpiperidin-4-ol, p38alpha MAPK Inhibitors targeting MAPK14 (Novartis, 10005638)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/10005638
Similar Terms
Downloads & Tools

Genes

13 genes differentially expressed following the AB-82-EP26_0.01uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
AKR1B15 aldo-keto reductase family 1, member B15 1.08763
SNRPD2 small nuclear ribonucleoprotein D2 polypeptide 16.5kDa 0.830733
FAU Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed 0.545222
TAGLN transgelin 0.510671
C19ORF33 chromosome 19 open reading frame 33 0.35686
KRT18 keratin 18, type I 0.337795
MYL6 myosin, light chain 6, alkali, smooth muscle and non-muscle 0.235854

decreased expression

Symbol Name Standardized Value
PRC1 protein regulator of cytokinesis 1 -0.545222
MRPS10 mitochondrial ribosomal protein S10 -0.392128
SLC38A2 solute carrier family 38, member 2 -0.335064
HNRNPUL1 heterogeneous nuclear ribonucleoprotein U-like 1 -0.255406
DHRS2 dehydrogenase/reductase (SDR family) member 2 -0.255406
TMEM41A transmembrane protein 41A -0.247339